(76 days)
The CurrentBody Skin Dual Light Hair Growth Helmet is indicated to promote hair growth in males with who have Norwood-Hamilton classifications of IIa-V or females with who have Ludwig-Savin Classifications of I-II and both with Fitzpatrick Skin Phototypes I-IV.
The CurrentBody Skin Dual Light Hair Growth Helmet (model:MZ-07A) is an over-the-counter device designed to promote hair growth in males who have Norwood-Hamilton Classifications of IIa-V patterns of hair loss and to promote hair growth in females who have Ludwig-Savin Classifications of I-II; both with Fitzpatrick Skin Types I-IV.
The device consists of 100 laser diodes with wavelength at 655±5nm, and 200 red light diodes with wavelength at 660±5nm.
The CurrentBody Skin Dual Light Hair Growth Helmet includes a hair-growing cap, a device base and a USB power cord. There are LEDs and lasers diodes inside the cap to emit visible red light, the device base acts as a support when the device is not used. There is a power button on cap to turn on/off the device, a digital display to show the remaining treatment time, an power indicator to show charging status and a USB port for charging.
The treatment parameter is pre-set by manufacturer, the device will auto off after treatment.
The provided FDA 510(k) clearance letter and summary for the CurrentBody Skin Dual Light Hair Growth Helmet (K251017) indicate that clinical performance testing was explicitly stated as "not needed" for this 510(k) submission. Therefore, the document does not contain information regarding acceptance criteria or a study that proves the device meets those criteria based on clinical performance data.
The submission relies on non-clinical performance testing to demonstrate substantial equivalence and safety/effectiveness. This non-clinical testing focuses on electrical safety, EMC, photobiological safety, battery safety, biocompatibility, and software validation.
Here's a breakdown of why the requested information about acceptance criteria and a clinical study proving performance cannot be extracted from this document, along with information that is available:
Acceptance Criteria and Device Performance (Based on Non-Clinical Testing)
Since no clinical performance study was provided, there are no specific performance acceptance criteria for hair growth or efficacy reported in the document. The acceptance criteria for this submission are related to meeting established safety and performance standards through non-clinical testing.
Table of Acceptance Criteria (Non-Clinical) and Reported Device Performance:
| Acceptance Criteria Category | Specific Standard/Requirement | Reported Device Performance / Compliance Statement |
|---|---|---|
| Electrical Safety | IEC 60601-1 (Ed 3.2 2020-08) | Evaluated by lab bench testing to comply |
| IEC 60601-1-11 (Ed 2.1 2020-07) (Home Healthcare) | Evaluated by lab bench testing to comply | |
| EMC | IEC 60601-1-2 (Ed 4.1 2020-09) | Evaluated by lab bench testing to comply |
| IEC TS 60601-4-2 (Ed 1.0 2024-03) | Evaluated by lab bench testing to comply | |
| Photobiological Safety | IEC 60601-2-57 (Ed 2.0 2023-07) | Evaluated by lab bench testing to comply |
| IEC 60825-1 (Ed 2.0 2007-03) (Laser Safety) | Evaluated by lab bench testing to comply | |
| IEC 62471 (Ed 1.0 2006-07) (Photobiological Safety) | Evaluated by lab bench testing to comply | |
| Battery Safety | IEC 62133-2 (Ed 1.0 2017-02) (Lithium Batteries) | Evaluated by lab bench testing to comply |
| Biocompatibility | ISO 10993-1, -5, -10 | Claims compliance; materials identical to K230336. Applicable tests: Cytotoxicity, Irritation/Intracutaneous Reactivity, Sensitization. |
| Software Validation | FDA Guidance for Software in Medical Devices ("Moderate" concern level) | Software V&V conducted and documentation provided as recommended. |
| Cybersecurity | FDA Guidance ("Content of Premarket Submissions for Management of Cybersecurity in Medical Devices") | Not needed as the device has no external interfaces. |
Regarding a Clinical Study (Not Applicable for this Submission)
As stated in Section 7.2 of the 510(k) Summary:
"Clinical testing was not needed for this 510(k). The non-clinical performance testing described above is sufficient to support that the device can be used safely and effectively."
Therefore, the following information, which would typically be included for a clinical study proving efficacy/performance, is not available in this document:
- Sample sizes used for the test set and the data provenance: Not applicable.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable.
- Adjudication method for the test set: Not applicable.
- If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable (This is generally for diagnostic AI devices, not a therapeutic device like this).
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable.
- The type of ground truth used: Not applicable.
- The sample size for the training set: Not applicable (referring to clinical training data for performance, not engineering/software validation training).
- How the ground truth for the training set was established: Not applicable.
Summary of Device Performance Claim Basis for Hair Growth:
The claim about promoting hair growth is based on:
- Substantial Equivalence: The primary strategy for clearance is demonstrating that the CurrentBody Skin Dual Light Hair Growth Helmet is substantially equivalent to legally marketed predicate devices (K231153: Neuhat Hair Growth System; K240456: Bosley Booster Laser Caps). The predicate devices were previously cleared for the same indication (promote hair growth in specific Norwood-Hamilton and Ludwig-Savin classifications with Fitzpatrick Skin Phototypes I-IV).
- Similarity in Design and Parameters: The submission highlights similarities in the intended use, indications for use, type of light (low-level laser and LED), wavelength (very close to predicates), number of diodes, energy per laser diode, and treatment time/irradiance (very close to predicates). The argument is that these similarities mean the subject device will have a similar therapeutic effect to the already-cleared predicate devices.
- Non-Clinical Data: As detailed in the table above, the non-clinical testing ensures the device meets safety standards (electrical, EMC, photobiological, battery, biocompatibility, software) which indirectly supports its safe use for its intended purpose without raising new questions of safety or effectiveness compared to the predicates.
FDA 510(k) Clearance Letter - CurrentBody Skin Dual Light Hair Growth Helmet
Page 1
U.S. Food & Drug Administration
10903 New Hampshire Avenue Doc ID# 04017.07.05
Silver Spring, MD 20993
www.fda.gov
June 17, 2025
Shenzhen Kaiyan Medical Equipment Co., Ltd
Alain Dijkstra
CEO
Building#3 and Building#5, 40th of Fuxin Street
Huaide Community Fuyong Town Baoan District
Shenzhen, Guangdong 518103
China
Re: K251017
Trade/Device Name: CurrentBody Skin Dual Light Hair Growth Helmet (model: MZ-07A)
Regulation Number: 21 CFR 890.5500
Regulation Name: Infrared Lamp
Regulatory Class: Class II
Product Code: OAP
Dated: March 31, 2025
Received: April 2, 2025
Dear Alain Dijkstra:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Page 2
K251017 - Alain Dijkstra Page 2
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic.
Page 3
K251017 - Alain Dijkstra Page 3
See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
TANISHA L. HITHE -S
Digitally signed by TANISHA L. HITHE -S
Date: 2025.06.17 15:35:14 -04'00'
Tanisha Hithe
Assistant Director
DHT4A: Division of General Surgery Devices
OHT4: Office of Surgical and Infection Control Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
Page 4
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120
Expiration Date: 07/31/2026
See PRA Statement below.
510(k) Number (if known): K251017
Device Name: CurrentBody Skin Dual Light Hair Growth Helmet (model: MZ-07A)
Indications for Use (Describe):
The CurrentBody Skin Dual Light Hair Growth Helmet is indicated to promote hair growth in males with who have Norwood-Hamilton classifications of IIa-V or females with who have Ludwig-Savin Classifications of I-II and both with Fitzpatrick Skin Phototypes I-IV.
Type of Use (Select one or both, as applicable):
- ☐ Prescription Use (Part 21 CFR 801 Subpart D)
- ☒ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Page 5
K251017 - 510(k) Summary
This summary of 510(K) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92.
1. Submitter Information
Sponsor Name: Shenzhen Kaiyan Medical Equipment Co., Ltd
Establishment Registration Number: 3011644607
Address: Building#3 and Building#5, 40th of Fuxin Street, Huaide Community Fuyong Town, Baoan District, Shenzhen, Guangdong 518103, China
Tel: 0755-82129361
Fax: 0755-25024651
Contact Person (including title): Alain Dijkstra (CEO)
E-mail: regulation@kaiyanmedical.com
Distributor
Company Name: CurrentBody.com Ltd
Address: Q17, Crossley Road, Stockport, Greater Manchester, SK4 5BB United Kingdom
Application Correspondent:
Contact Person: Mr. Alain Dijkstra
Company: Shenzhen Kaiyan Medical Equipment Co., Ltd
Address: Building#3 and Building#5, 40th of Fuxin Street, Huaide Community Fuyong Town, Baoan District, Shenzhen, Guangdong 518103, China
Tel: +86 755 82129361
Fax: +86 755 25024651
Email: regulation@kaiyanmedical.com
2. Summary Prepared Date
23 May 2025
3. Subject Device Information
Trade Name: CurrentBody Skin Dual Light Hair Growth Helmet
Model: MZ-07A
Common Name: Laser, Comb, Hair
Classification Name: Infrared Lamp
Review Panel: General & Plastic Surgery
Product Code: OAP
Regulation Number: 21 CFR 890.5500
Regulation Class: II
4. Predicate Device Information
Page 6
Primary Predicate Device Information
Sponsor: Nature Incredible Inc.
Trade Name: Neuhat Hair Growth System (or ibeauty.com Laser Cap)
Model: NEU300, NEU180
510(k) Number: K231153
Review Panel: General & Plastic Surgery
Regulatory Class: Class II
Regulatory Code: OAP
Regulation: 21 CFR 890.5500
Reference device
Sponsor: Ronald E. Berglund, GRACE Consulting, LLC
Trade Name: Bosley Booster 128 Laser Cap; Bosley Booster 162 Laser Cap; Bosley Booster 288 Laser Cap
Model: 128 model, 162 model, 288 model
510(k) Number: K240456
Review Panel: General & Plastic Surgery
Regulatory Class: Class II
Regulatory Code: OAP
Regulation: 21 CFR 890.5500
5. Device Description
The CurrentBody Skin Dual Light Hair Growth Helmet (model:MZ-07A) is an over-the-counter device designed to promote hair growth in males who have Norwood-Hamilton Classifications of IIa-V patterns of hair loss and to promote hair growth in females who have Ludwig-Savin Classifications of I-II; both with Fitzpatrick Skin Types I-IV.
The device consists of 100 laser diodes with wavelength at 655±5nm, and 200 red light diodes with wavelength at 660±5nm.
The CurrentBody Skin Dual Light Hair Growth Helmet includes a hair-growing cap, a device base and a USB power cord. There are LEDs and lasers diodes inside the cap to emit visible red light, the device base acts as a support when the device is not used. There is a power button on cap to turn on/off the device, a digital display to show the remaining treatment time, an power indicator to show charging status and a USB port for charging.
The treatment parameter is pre-set by manufacturer, the device will auto off after treatment.
6. Intended Use
Page 7
The CurrentBody Skin Dual Light Hair Growth Helmet is indicated to promote hair growth in males with who have Norwood-Hamilton classifications of IIa-V or females with who have Ludwig-Savin Classifications of I-II and both with Fitzpatrick Skin Phototypes I-IV.
7. Comparison to Predicate Device
Compare with predicate device, the subject device is very similar in design principle, intended use, indications for use, functions and the applicable standards. The differences between subject device and predicate device do not raise and new questions of safety or effectiveness.
| Elements of Comparison | Subject Device | Primary predicate | Reference device | Verdict |
|---|---|---|---|---|
| Company | Shenzhen Kaiyan Medical Equipment Co., Ltd | Nature Incredible Inc. | Ronald E. Berglund, GRACE Consulting, LLC | -- |
| Trade Name | CurrentBody Skin Dual Light Hair Growth Helmet | Neuhat Hair Growth System (or ibeauty.com Laser Cap) | Bosley Booster 128 Laser Cap; Bosley Booster 162 Laser Cap; Bosley Booster 288 Laser Cap | -- |
| 510(k) Number | Applying | K231153 | K240456 | -- |
| Regulation number | 21 CFR 890.5500 | 21 CFR 890.5500 | 21 CFR 890.5500 | Same |
| Classification Name | Infrared Lamp | Infrared Lamp | Infrared Lamp | Same |
| Product Code | OAP | OAP | OAP | Same |
| Class | II | II | II | Same |
Page 8
| Elements of Comparison | Subject Device | Primary predicate | Reference device | Verdict |
|---|---|---|---|---|
| Intended Use / Indications for Use | The CurrentBody Skin Dual Light Hair Growth Helmet is indicated to promote hair growth in males with androgenic alopecia who have Norwood-Hamilton classifications of IIa | Neuhat Hiar Growth System is indicated to promote hair growth in males with androgenic alopecia who have Norwood-Hamilton classifications of IIa-V and females with addrogneic alopecia who have Ludwig-Savin Classifications of I-II and Fitzpatrick Classification of Skin Phototypes I-IV. ibeauty.com Laser Cap is indicated to promote hair growth in males with androgenic alopecia who have Norwood-Hamilton classifications of IIa-V and females with addrogneic alopecia who have Ludwig-Savin Classifications of I-II and Fitzpatrick Classification of Skin Phototypes I-IV. | Indicated to promote hair growth in males with androgenetic alopecia who have Hamilton-Norwood Classifications of IIa-V and females with androgenetic alopecia who have Ludwig-Savin Classifications of I – II and Fitzpatrick Classification of Skin Phototypes I to IV. | Same |
| Location for use | OTC | OTC | OTC | Same |
| Intended User | Both sex | Both sex | Both sex | Same |
| Type of light | Low-level laser diodes and light emitting diodes | Low-level laser diodes and light emitting diodes | Low-level laser diodes and light-emitting diodes | Same |
| Wavelength | Laser: 655 ±5nm LED: 660 ± 5nm | Laser: 655nm Red light LED: 650nm | 650nm | Similar Note1 |
| Number of diodes | Laser diodes: 100 LED diodes: 200 | NEU300 Laser diodes: 100 LED diodes: 200 NEU180 Laser diodes: 50 LED diodes: 130 | 288 model: 115 LDs, 173 LEDs | Same |
Page 9
| Elements of Comparison | Subject Device | Primary predicate | Reference device | Verdict |
|---|---|---|---|---|
| Energy of per laser diode | 5 mw | 5mw | 5mW per light | Same |
| Distribution | Uniform | Not public available | Uniform | Same |
| Treatment Time | Every day 20 mins | Each treatment: 25 mins Total Treatment: 16 weeks, every other day (indefinite) | 25 minutes every day | Same Note 2 |
| Irradiance | 2.85 mw/cm² | Not public available | 2.47 mw/cm² | Same Note 2 |
| Applicable people | Norwood-Hamilton IIa | Norwood-Hamilton IIa | Norwood-Hamilton IIa | Same |
| Applicable skin | Fitzpatrick Skin Phototypes I-IV | Fitzpatrick Skin Phototypes I-IV | Fitzpatrick Skin Phototypes I-IV | Same |
| Helmet/Cap design | Yes | Yes | Yes | Same |
| Biocompatibility feature | All body-contacting materials are complied with ISO10993-5 and ISO 10993-10 | All body-contacting materials are complied with ISO10993-5 and ISO 10993-10 | Not public available | Same |
Comparison in Detail(s):
Note 1:
Though the wavelength of subject device is a little different from predicate devices, it is very close to predicate devices. Therefore, this slight difference will not raise any effectiveness or safety issue.
Note 2:
The treatment time and irradiance of the subject device are a little difference from the predicate devices but very close. Therefore, this slight difference will not raise any effectiveness or safety issue.
8. Test Summary
7.1 Summary of Non-Clinical Performance Testing
1) Performance Testing Summary
The CurrentBody Skin Dual Light Hair Growth Helmet (Model: MZ-07A) has been evaluated the safety and performance by lab bench testing as following:
Page 10
| Standards No. | Standard Title | Version | Recognition Number |
|---|---|---|---|
| IEC 60601-1 | Medical electrical equipment - Part 1: General requirements for basic safety and essential performance | Edition 3.2 2020-08 | 19-49 |
| IEC 60601-1-11 | Medical electrical equipment - Part 1-11: General requirements for basic safety and essential performance - Collateral Standard: Requirements for medical electrical equipment and medical electrical systems used in the home healthcare environment | Edition 2.1 2020-07 | 19-38 |
| IEC 60601-1-2 | Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral Standard: Electromagnetic disturbances - Requirements and tests | Edition 4.1 2020-09 | 19-36 |
| IEC TS 60601-4-2 | Medical electrical equipment - Part 4-2: Guidance and interpretation - Electromagnetic immunity: performance of medical electrical equipment and medical electrical systems | IEC TS 60601-4-2: Edition 1.0 2024-03 | 19-50 |
| IEC 60601-2-57 | Medical Electrical Equipment - Part 2-57: Particular requirements for the basic safety and essential performance of non-laser light source equipment intended for therapeutic diagnostic monitoring and cosmetic/aesthetic use | Edition 2.0 2023-07 | 12-355 |
| IEC 60825-1 | Safety of laser products - Part 1: Equipment classification and requirements [Including: Technical Corrigendum 1 (2008) Interpretation Sheet 1 (2007) Interpretation Sheet 2 (2007)] | Edition 2.0 2007-03 | 12-273 |
Page 11
| Standards No. | Standard Title | Version | Recognition Number |
|---|---|---|---|
| IEC 62471 | Photobiological safety of lamps and lamp systems | First edition 2006-07 | 12-249 |
| IEC 62133-2 | Secondary cells and batteries containing alkaline or other non-acid electrolytes - Safety requirements for portable sealed secondary cells and for batteries made from them for use in portable applications - Part 2: Lithium systems | Edition 1.0 2017-02 | 19-33 |
2) Biocompatibility
The patient directly contracting materials in the subject device are showed in the following list.
| Components of Subject Device | Material of Components | Body Contact Category (ISO 10993-1) | Contact Duration (ISO 10993-1) |
|---|---|---|---|
| Inner surface of cap | Silicone | Surface-contacting device: skin | A-limited(<24h) |
The Nature of body contact is Surface medical device-Intact skin contact. And the contact duration is less than 24 hours. According to Table 1 - Initial evaluation tests for consideration in ISO 10993-1, the applicable biological effect is:
- Cytotoxicity
- Irritation or intracutaneous reactivity
- Sensitization
The inner surface of cap (silicone) is identical to cleared device K230336 in formulation, processing, and cleaning, and no other chemicals have been added (e.g., plasticizers, fillers, color additives, cleaning agents, mold release agents. Etc.).
3) Software verification and validation testing
Software verification and validation testing were conducted and documentation was provided as recommended by FDA'S Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices." The software for this device was considered as a "moderate" level concern, since a malfunction of, or a latent design flaw in, the Software Device leads to an erroneous diagnosis or a delay in delivery of appropriate medical care that would likely lead to Minor Injury.
4) Cybersecurity
The subject device no any external interfaces, according to FDA guidance "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices", no need cybersecurity evaluation.
Page 12
7.2 Clinical Performance
Clinical testing was not needed for this 510(k). The non-clinical performance testing described above is sufficient to support that the device can be used safely and effectively.
9. Conclusion
The subject device is as safe, as effective, and performs as well as or better than the legally marketed predicated device K231153 and K240456.
§ 890.5500 Infrared lamp.
(a)
Identification. An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.(b)
Classification. Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.